Position in MRNA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,023,558
+$519,826 QoQ
Shares Held
14,616
+47.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#297
of 773 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Dec 31, 2022CallValue
$1,650
CallShares
300
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $4,203,874 across 8 Biotechnology names. MRNA ranks #2 (24.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,390 | $1,683,914 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
14,616 | $1,023,558 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,330 | $570,314 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
645 | $402,183 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
6,732 | $367,163 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
19,550 | $71,748 | |
| 7 | IMRX |
Immuneering Corp
|
10,000 | $49,900 | |
| 8 | NGEN |
Nervgen Pharma Corp.
|
17,036 | $35,094 |
All Filings in MRNA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,023,558 | 14,616 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $503,732 | 9,916 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $485,759 | 16,472 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $507,223 | 19,637 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $581,790 | 21,087 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $575,136 | 20,287 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,346,068 | 56,423 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,640,163 | 54,469 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $5,471,881 | 46,079 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,898,456 | 45,969 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $3,982,972 | 40,050 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,881,894 | 27,901 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,241,322 | 34,908 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $5,536,098 | 36,047 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $6,523,439 | 36,318 | Shares | Sole | 2023-02-10 | |
| 2022-12-31 | $1,650 | 300 | Call | Sole | 2023-02-10 | |
| 2022-09-30 | $4,354,319 | 36,823 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,305,020 | 37,137 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $6,339,684 | 36,803 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $9,657,081 | 38,023 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,045,331 | 39,093 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $10,767,723 | 45,824 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,054,080 | 46,232 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,772,816 | 45,686 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,209,998 | 45,371 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $3,157,912 | 49,181 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,875,439 | 62,619 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||